Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors

OBJECTIVE: The predictive biomarkers of immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) still need to be further explored. This study aims to establish a new immune prognosis biomarker to predict the clinical outcomes of hepatocellular carcinoma patients receiving immune checkp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rujia, Zhao, Haoran, Wang, Peng, Guo, Zuoming, Liu, Chunxun, Qu, Zhaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693152/
https://www.ncbi.nlm.nih.gov/pubmed/38041022
http://dx.doi.org/10.1186/s12885-023-11678-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693152/
https://www.ncbi.nlm.nih.gov/pubmed/38041022
http://dx.doi.org/10.1186/s12885-023-11678-5

Ejemplares similares